News Brief

8/17/2009, Av 27, 5769

Israeli Co. Wins National Grant for Parkinson's Patch

Israeli company NeuroDerm has earned a $400,000 grant from the Office of the Chief Scientist for the development of a transdermal patch to treat Parkinson's disease. The company is in the process of developing skin patches for various neurological diseases.

The company was founded by chief scientist Prof. Eliyahu Heldman and its chairman and CEO is Dr. Oded Lieberman.